Escitalopram Acid
✓
데이터 정확도 100%
연중무휴 과학적 지원
⬡
제품 품질에 대한 무관용 원칙

재고 위치

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

Escitalopram Acid

● 재고 있음

카탈로그 번호:VE0025655
CAS 번호:N/A
분자식:C20H21FN2O3
분자량:356.39 g/mol

에 대한 추가 정보

모약물

Escitalopram

IUPAC명

5-cyano-2-(4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)benzoic acid

동의어

5-cyano-2-(4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)benzoic acid

SMILES

O=C(O)C1=CC(C#N)=CC=C1C(C2=CC=C(F)C=C2)(CCCN(C)C)O

InChI

InChI=1S/C20H21FN2O3/c1-23(2)11-3-10-20(26,15-5-7-16(21)8-6-15)18-9-4-14(13-22)12-17(18)19(24)25/h4-9,12,26H,3,10-11H2,1-2H3,(H,24,25)

설명

Escitalopram Acid, 5-cyano-2-(4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)benzoic acid, is a polar acidic degradation impurity observed during synthesis and stability of escitalopram. It can form via oxidative hydrolysis and exhibits increased polarity relative to the parent amine, leading to early HPLC retention and a characteristic [M-H]- ion in LC-MS. Control strategies include validated HPLC-UV and LC-MS assays, forced degradation profiling, and NMR confirmation for structural assignment. Specification limits are set based on ICH impurity thresholds and toxicological assessment. Monitoring this impurity is essential for API quality, process optimization, and regulatory compliance.

견적 요청

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url